21:11:37 EST Sun 28 Nov 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Opsens Inc
Symbol OPS
Shares Issued 90,280,317
Close 2021-01-06 C$ 1.41
Recent Sedar Documents

Opsens to provide Q1 results Jan. 13

2021-01-06 09:40 ET - News Release

Mr. Louis Laflamme reports

OPSENS TO HOST FIRST QUARTER FISCAL YEAR 2021 FINANCIAL RESULTS CONFERENCE CALL ON WEDNESDAY, JANUARY 13, 2021

Opsens Inc. will provide its financial results for its first quarter of fiscal year 2021, ended Nov. 30, 2020, on Wednesday, Jan. 13, 2021, before the open of the market. The company has scheduled a conference call that same day, Wednesday, Jan. 13, 2021, at 11 a.m. ET, to review the results.

Interested parties can access the conference call by dialling 877-270-2148 or 412-902-6510 or can listen via a live Internet webcast, which is available in the investors section of the company's website.

A teleconference replay of the call will be available for three days at 877-344-7529 or 412-317-0088, confirmation No. 10150894. A webcast replay will be available in the investors section of the company's website.

About Opsens Inc.

Opsens focuses mainly on coronary artery stenosis measurement in interventional cardiology. The company offers an advanced optical-based pressure guide wire that aims at improving the clinical outcome of patients with coronary artery disease. Its flagship product, the OptoWire, is a second-generation fibre optic pressure guidewire designed to provide the lowest drift in the industry and excellent lesions access. The OptoWire has been used in the diagnosis and treatment of over 100,000 patients in more than 30 countries. It is approved for sale in the United States, European Union, Japan and Canada.

Opsens is also involved in industrial activities in developing, manufacturing and installing innovative fibre optic sensing solutions for critical applications.

© 2021 Canjex Publishing Ltd. All rights reserved.